Angsana Molecular and Diagnostics Pte Ltd Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Angsana Molecular and Diagnostics Pte Ltd's estimated annual revenue is currently $2M per year.(i)
  • Angsana Molecular and Diagnostics Pte Ltd's estimated revenue per employee is $155,000

Employee Data

  • Angsana Molecular and Diagnostics Pte Ltd has 13 Employees.(i)
  • Angsana Molecular and Diagnostics Pte Ltd grew their employee count by -35% last year.

Angsana Molecular and Diagnostics Pte Ltd's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Angsana Molecular and Diagnostics Pte Ltd?

Established in 2014, Angsana Molecular & Diagnostics Laboratory Pte td is a multinational company specialising in developing premium genomics assays in four areas that have the largest impact on the Asian population- Molecular Oncology, Fetal & Maternal Health, Allergy & Immunology and Pharmacogenomics Vision - Angsana Molecular & Diagnostics aims to be a life company committed to better healthcare for humanity's tomorrow. Mission - We are a diverse team of dedicated experts collectively committed to helping individuals and communities in Asia manage their healthcare conditions, so they not only live better, but also smarter. Driven to continuously improve, we provide cutting edge molecular diagnostics services, actionable personalised medical insights and practical public education to empower doctors and patients in making better informed decisions.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

-35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.6M138%N/A
#2
$1.1M13-24%N/A
#3
$1.2M14-18%N/A
#4
$1.3M1536%N/A
#5
$3.8M15-25%N/A